Peptide directory.
Find the molecule. Understand the research. Follow the source. Browse 35 dossiers with aliases, biological context and source-linked evidence.

Retatrutide
LY3437943
Multi-receptor metabolic research in defined clinical populations.

Selank
Tuftsin-related analogue
Neurobehavioral and exploratory clinical research.

Semaglutide
GLP-1 receptor agonist
Glycemic and body-weight outcomes in randomized clinical trials.

Semax
ACTH-related analogue
Neurotrophic signaling in experimental models.

Sermorelin
GHRH(1–29)
Pituitary GH stimulation and short-term endocrine responses.

Survodutide
BI 456906
Weight-management and metabolic liver-disease clinical research.

TB-500
TB500
Molecular identity and the gap between fragment and full-length peptide evidence.

Tesamorelin
GHRH analogue
Visceral adipose tissue in specific HIV-associated clinical contexts.

Thymosin alpha-1
Thymosin α1
Indication-specific immune research, including randomized sepsis trials.

Thymosin beta-4
Tβ4
Actin-associated cell biology and experimental tissue research.

Tirzepatide
Dual GIP / GLP-1 receptor agonist
Metabolic outcomes in randomized phase 3 studies.
Evidence labels describe the cited sources, not a complete systematic review, a safety rating or regulatory approval. This archive does not yet cover every peptide.